Skip to Main Content.

Industries

Practices

Biography

Amy focuses her practice on technology transfer and the commercial agreements emerging companies need to grow, from IP licenses and material transfer agreements to NDAs and services agreements. She draws on a background in drug discovery, clinical research, and university commercialization to help research institutions and life sciences startups move innovations from the lab to the market.

Before law school, Amy worked as a laboratory technician in a medicinal chemistry lab at the University of Kentucky College of Pharmacy. She is a named co-author on eight peer-reviewed publications on infectious disease drug discovery resulting from that work. She then managed neuro-oncology trials as a clinical research coordinator at UK’s Markey Cancer Center. Later, as a clinical research associate at Parexel, she led regulatory and ethics submissions for global study start-up, completing her narrative of drug discovery from bench to bedside.

Amy’s technology transfer experience began as a fellow on the Intellectual Property Development Team at UK’s Office of Technology Commercialization. There she conducted patentability assessments, evaluated invention disclosures, and performed IP diligence. She returned to that office as a legal intern during law school, drafting and negotiating a wide range of technology transfer agreements, including data use and inter-institutional agreements.

She also spent a summer with the Office of Legal Services at St. Jude Children’s Research Hospital, where she worked on a range of technology transfer and clinical trial agreement matters. Her law school experience further includes FDA regulatory consulting, an externship with UK’s Office of Legal Counsel, and an externship with the healthcare privacy team at UK HealthCare’s Office of Corporate Compliance.

*Licensed only in KY

Other Info About Amy

Education

Law School

University of Kentucky College of Law, J.D., cum laude, 2026

Undergraduate School

Thomas More College, B.S., Biology, A.A., Chemistry, 2018

Bar Memberships

Amy is licensed to practice in the following state(s):

Kentucky

Recognition

Local & National Recognition

Award Selection Methodology

University of Kentucky J. David Rosenberg College of Law, Pro Bono Award Recipient

Major Publications

Amy is an author or contributor to the following publications:

Kim HS, Ortiz D, Kadayat TM, Fargo CM, Hammill JT, Chen Y, Rice AL, Begley KL, Shoeran G, Pistel W, Yates PA, Sanchez MA, Landfear SM, Guy RK. Optimization of orally bioavailable antileishmanial 2,4,5-trisubstituted benzamides. J Med Chem. 2023;66(11):7374-7386. doi:10.1021/acs.jmedchem.3c00056

Eagon S, Hammill JT, Fitzsimmons K, Sienko N, Nguyen B, Law J, Manjunath A, Wilkinson SP, Thompson K, Glidden JE, Rice AL, Falade MO, Kimball JJ, DiBernardo C, Guy RK. Antimalarial activity of 2,6-dibenzylidenecyclohexanone derivatives. Bioorg Med Chem Lett. 2021;47:128216. doi:10.1016/j.bmcl.2021.128216

Hammill JT, Sviripa VM, Kril LM, Ortiz D, Fargo CM, Kim HS, Chen Y, Rector J, Rice AL, Domagalska MA, Begley KL, Liu C, Rangnekar VM, Dujardin JC, Watt DS, Landfear SM, Guy RK. Amino-substituted 3-aryl- and 3-heteroarylquinolines as potential antileishmanial agents. J Med Chem. 2021;64(16):12152-12162. doi:10.1021/acs.jmedchem.1c00813

Kim HS, Hammill JT, Scott DC, Chen Y, Rice AL, Pistel W, Singh B, Schulman BA, Guy RK. Improvement of oral bioavailability of pyrazolo-pyridone inhibitors of the interaction of DCN1/2 and UBE2M. J Med Chem. 2021;64(9):5850-5862. doi:10.1021/acs.jmedchem.1c00035

Everson N, Bach J, Hammill JT, Falade MO, Rice AL, Guy RK, Eagon S. Identification of Plasmodium falciparum heat shock 90 inhibitors via molecular docking. Bioorg Med Chem Lett. 2021;35:127818. doi:10.1016/j.bmcl.2021.127818

Barrows RD, Hammill JT, Tran MC, Falade MO, Rice AL, Davis CW, Emge TJ, Rablen PR, Guy RK, Knapp S. Evaluation of 1,1-cyclopropylidene as a thioether isostere in the 4-thio-thienopyrimidine (TTP) series of antimalarials. Bioorg Med Chem. 2020;28(22):115758. doi:10.1016/j.bmc.2020.115758

Eagon S, Hammill JT, Bach J, Everson N, Sisley TA, Walls MJ, Durham S, Pillai DR, Falade MO, Rice AL, Kimball JJ, Lazaro H, DiBernardo C, Guy RK. Antimalarial activity of tetrahydro-β-carbolines targeting the ATP binding pocket of the Plasmodium falciparum heat shock 90 protein. Bioorg Med Chem Lett. 2020;30(21):127502. doi:10.1016/j.bmcl.2020.127502

Eagon S, Hammill JT, Sigal M, Ahn KJ, Tryhorn JE, Koch G, Belanger B, Chaplan CA, Loop L, Kashtanova AS, Yniguez K, Lazaro H, Wilkinson SP, Rice AL, Falade MO, Takahashi R, Kim K, Cheung A, DiBernardo C, Kimball JJ, Winzeler EA, Eribez K, Mittal N, Gamo FJ, Crespo B, Churchyard A, García-Barbazán I, Baum J, Anderson MO, Laleu B, Guy RK. Synthesis and structure–activity relationship of dual-stage antimalarial pyrazolo[3,4-b]pyridines. J Med Chem. 2020;63(20):11902-11919. doi:10.1021/acs.jmedchem.0c01152